At a glance
ClinicalIndex Comparison RecordN/ACompleted· 368 enrolled
Drug / intervention
Routine practice group +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)
In Brief
A clinical study evaluating Routine practice group and EARP group for Psoriasis. Completed, enrolled 368 participants across 15 sites.
Detailed Summary
This was a randomized, open, parallel, controlled, multi-center, interventional, cross-sectional study to evaluate the detection rate of Psoriatic arthritis (PsA) in Korean moderate to severe Psoriasis (PsO) patients with or without the Early arthritis for psoriatic patients (EARP) screening.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartOct 2022
First PostedMar 2023
Primary CompletionJun 2023
TodayJul 2026
First PostedMar 7, 2023
Enrollment StartOct 20, 2022
Primary CompletionJun 30, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.3 years ago
Interventions
Routine practice groupother
Routine practice group
EARP groupother
EARP group